Blood glucose modulation via delayed starch absorption pathway

The "Blood glucose modulation via delayed starch absorption pathway" refers to strategies aimed at slowing down the digestion and subsequent absorption of dietary starches in order to reduce postprandial hyperglycemia. This process primarily involves inhibiting key digestive enzymes—such as pancreatic amylase and brush border membrane-bound glucosidases—that break down complex carbohydrates into absorbable monosaccharides like glucose. Additionally, modulating sodium-dependent hexose transporters such as SGLT1 can further slow intestinal sugar uptake. The net effect is blunted post-meal rises in blood sugar levels. This approach has therapeutic relevance for managing type 2 diabetes mellitus and metabolic syndrome by improving glycemic control without increasing insulin secretion. Drugs targeting this pathway include acarbose-like compounds that inhibit digestive enzymes responsible for breaking down complex carbohydrates before they are absorbed through specific transporters on enterocytes lining the small intestine. Biomarkers used include oral tolerance tests measuring changes in plasma/serum concentrations after ingestion challenges with standardized meals containing known amounts/compositions.

Other names

Delayed carbohydrate absorption pathwayStarch digestion and absorption inhibitionGlycemic control via starch digestion delay

Inhibition of α-amylase and/or α-glucosidase enzymes in the small intestine delays breakdown of complex carbohydrates into absorbable monosaccharides like glucose. This results in slower glucose absorption from the gut into the bloodstream, reducing postprandial blood glucose spikes. Some plant metabolites may also modulate other targets involved in insulin sensitivity or glucose transport. Sodium-dependent hexose transporter SGLT1 mediates active uptake of glucose from intestinal lumen into enterocytes. Inhibition or downregulation of SGLT1 can further delay carbohydrate absorption. Resistant starch acts by escaping small intestinal digestion and being fermented by colonic microbiota to produce short-chain fatty acids that influence systemic metabolism.